Inactive Instrument

IntriCon Corporation

Equities

IIN

US46121H1095

Medical Equipment, Supplies & Distribution

IntriCon Corporation Provides Revenue Guidance for the First Quarter of Fiscal 2021

February 26, 2021 at 03:30 am IST

IntriCon Corporation provided revenue guidance for the first quarter of fiscal 2021. The company expects steady growth throughout the year, with the first quarter revenue slightly lower than fourth quarter 2020 as COVID variants have provided some degree of headwind.

Latest news about IntriCon Corporation

IntriCon Corporation(NasdaqGM:IIN) dropped from S&P TMI Index	25/22/25	CI
IntriCon Corporation(NasdaqGM:IIN) dropped from S&P Global BMI Index	25/22/25	CI
Intricon Corporation Announces Board Changes	25/22/25	CI
IntriCon Corporation(NasdaqGM:IIN) dropped from NASDAQ Composite Index	24/22/24	CI
Altaris Capital Partners, LLC completed the acquisition of IntriCon Corporation from Gabelli Funds, LLC, Beryl Capital Management LLC, Royce & Associates, LP and others.	24/22/24	CI
IntriCon Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	10/22/10	CI
Sector Update: Health Care Stocks Finishing Above Intraday Lows	01/22/01	MT
Colliers Securities Downgrades IntriCon to Neutral From Buy	01/22/01	MT
Top Midday Gainers	01/22/01	MT
Sector Update: Health Care Stocks Sinking Monday But Biotechs, Deal-Making Helping Limit Slide	28/22/28	MT
Intricon Agrees to be Acquired by Altaris Capital Partners for $241 Million; Shares Surge Premarket	28/22/28	MT
IntriCon Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
IntriCon Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	28/22/28	CI
Earnings Flash (IIN) INTRICON CORPORATION Reports Q4 Revenue $32.2M	28/22/28	MT
Earnings Flash (IIN) INTRICON CORPORATION Reports Q4 EPS $0.23	28/22/28	MT
Altaris Capital Partners, LLC entered into a definitive agreement to acquire IntriCon Corporation from Gabelli Funds, LLC, Beryl Capital Management LLC, Royce & Associates, LP and others for approximately $230 million.	28/22/28	CI
Ellen Scipta Steps Down as Chief Financial Officer	02/21/02	CI
Transcript : IntriCon Corporation, Q3 2021 Earnings Call, Nov 08, 2021	09/21/09
Earnings Flash (IIN) INTRICON CORPORATION Reports Q3 Revenue $31.1M, vs. Street Est of $31.1M	09/21/09	MT
Earnings Flash (IIN) INTRICON CORPORATION Posts Q3 EPS $0.17, vs. Street Est of $0.02	09/21/09	MT
IntriCon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/21/09	CI
IntriCon Corporation Revises Revenue Guidance for the Year 2021	09/21/09	CI
IntriCon CFO Steps Down; Reports Preliminary Q3 Revenue	30/21/30	MT
IntriCon Corporation Announces CFO Changes	30/21/30	CI
IntriCon Corporation Announces Revenue Guidance for the Quarter ended September 30, 2021	30/21/30	CI

Chart IntriCon Corporation

Duration

Period

More charts

Company Profile

Intricon Corporation is a joint development manufacturer (JDM) of micro medical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micro medical devices components and subassemblies for medical markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete catheter-based and body-worn devices for medical device manufacturers. The Company serves its market by offering medical device manufacturers, which have the capabilities to design, develop, manufacture, package and distribute medical devices. It operates globally with facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-7.16%	178B
BECTON, DICKINSON AND COMPANY	-4.86%	67.04B
DEXCOM, INC.	-4.28%	47.24B
CENCORA, INC.	+10.32%	44.62B
HOYA CORPORATION	+8.14%	42.5B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.76%	29.99B
TERUMO CORPORATION	+15.53%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	24.14B
ZIMMER BIOMET HOLDINGS, INC.	-5.38%	23.69B

Other Medical Equipment, Supplies & Distribution